White Pine Capital’s AngioDynamics ANGO Stock Holding History

White Pine Capital’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42M	Sell	124,615 -25,909	-17%	-$281K	0.4%	79
2025 Q4	$1.93M	Buy	150,524 +45,384	+43%	+$560K	0.53%	56
2025 Q3	$1.17M	Buy	105,140 +40,060	+62%	+$387K	0.34%	83
2025 Q2	$646K	Buy	65,080 +942	+1%	+$9.22K	0.2%	137
2025 Q1	$602K	Buy	64,138 +105	+0.2%	+$1.1K	0.21%	122
2024 Q4	$587K	Buy	64,033 +41,925	+190%	+$308K	0.2%	133
2024 Q3	$172K	Buy	+22,108	New	+$160K	0.06%	214
2018 Q1	–	Sell	-25,875	Closed	-$430K	–	242
2017 Q4	$430K	Buy	25,875 +100	+0.4%	+$1.71K	0.16%	154
2017 Q3	$440	Sell	25,775 -1,375	-5%	-$23.1K	﹤0.01%	151
2017 Q2	$440K	Sell	27,150 -2,825	-9%	-$44.7K	0.17%	154
2017 Q1	$520K	Hold	29,975	–	–	0.21%	136
2016 Q4	$506K	Hold	29,975	–	–	0.21%	126
2016 Q3	$526K	Sell	29,975 -7,000	-19%	-$114K	0.22%	131
2016 Q2	$531K	Sell	36,975 -40,650	-52%	-$508K	0.22%	137
2016 Q1	$954K	Sell	77,625 -50	-0.1%	-$552	0.41%	67
2015 Q4	$943K	Sell	77,675 -1,225	-2%	-$15.1K	0.42%	71
2015 Q3	$1.04M	Sell	78,900 -2,000	-2%	-$30.2K	0.48%	55
2015 Q2	$1.33M	Sell	80,900 -3,100	-4%	-$51.5K	0.57%	47
2015 Q1	$1.49M	Sell	84,000 -425	-0.5%	-$7.9K	0.61%	46
2014 Q4	$1.6M	Sell	84,425 -4,300	-5%	-$72.9K	0.54%	56
2014 Q3	$1.22M	Buy	88,725 +16,225	+22%	+$232K	0.41%	78
2014 Q2	$1.18M	Hold	72,500	–	–	0.41%	78
2014 Q1	$1.14M	Sell	72,500 -350	-0.5%	-$5.7K	0.39%	78
2013 Q4	$1.25M	Sell	72,850 -50	-0.1%	-$769	0.44%	69
2013 Q3	$962K	Buy	72,900 +59,375	+439%	+$700K	0.33%	89
2013 Q2	$153K	Buy	+13,525	New	+$144K	0.05%	223

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

White Pine Capital's ANGO Position: Q1 2026 in Review

White Pine Capital reduced its AngioDynamics (ANGO) stake by 17% in Q1 2026, selling an estimated $281K and leaving 124,615 shares worth $1.42M. The position accounts for 0.4% of the portfolio, ranked #79.

White Pine Capital first reported a position in ANGO in Q2 2013 and has held it in 26 quarters since. The position peaked at $1.93M in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

White Pine Capital held 124,615 shares of AngioDynamics worth $1.42M as of Q1 2026.
White Pine Capital sold 25,909 AngioDynamics shares in Q1 2026, an estimated $281K.
AngioDynamics made up 0.4% of White Pine Capital's portfolio in Q1 2026, its #79 holding.
White Pine Capital first reported a position in AngioDynamics in Q2 2013 and has held it in 26 quarters since.
White Pine Capital's AngioDynamics position peaked at $1.93M in Q4 2025.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on White Pine Capital's 13F filing for Q1 2026, filed 11 May 2026.